Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038082
Filing Date
2023-08-03
Accepted
2023-08-03 16:31:02
Documents
41
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-20230630.htm   iXBRL 10-Q 1091638
2 EX-31.1 mack-ex31_1.htm EX-31.1 14363
3 EX-31.2 mack-ex31_2.htm EX-31.2 14363
4 EX-32.1 mack-ex32_1.htm EX-32.1 9965
5 EX-32.2 mack-ex32_2.htm EX-32.2 9965
  Complete submission text file 0000950170-23-038082.txt   3545208

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mack-20230630.xsd EX-101.SCH 22825
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mack-20230630_def.xml EX-101.DEF 61178
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mack-20230630_cal.xml EX-101.CAL 20331
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mack-20230630_lab.xml EX-101.LAB 194892
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mack-20230630_pre.xml EX-101.PRE 131106
35 EXTRACTED XBRL INSTANCE DOCUMENT mack-20230630_htm.xml XML 525404
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 231140601
SIC: 2834 Pharmaceutical Preparations